|
Volumn 56, Issue 5, 2007, Pages 854-855
|
Antipsoriatic biologic agents for the treatment of atopic dermatitis
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ALEFACEPT;
CEFALEXIN;
DICLOXACILLIN;
EFALIZUMAB;
ETANERCEPT;
INFLIXIMAB;
ARTICLE;
ATOPIC DERMATITIS;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG USE;
HUMAN;
IMMUNOMODULATION;
INFLAMMATION;
LEUKOCYTE FUNCTION;
PRIORITY JOURNAL;
REBOUND;
SIDE EFFECT;
STAPHYLOCOCCUS;
STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS INFECTION;
TH2 CELL;
THROMBOCYTOPENIA;
URTICARIA;
VIRAL GASTROENTERITIS;
VIRUS INFECTION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
DERMATITIS, ATOPIC;
DERMATOLOGIC AGENTS;
HUMANS;
IMMUNOGLOBULIN G;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
EID: 34147116720
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2006.12.034 Document Type: Article |
Times cited : (5)
|
References (6)
|